Parenteral Excipients

Abstract Inflammatory bowel disease (IBD) affects over 7 million people worldwide and significant side effects are associated with current therapies...

Lactose is a well known excipient as bulking agent in freeze-dried parenteral products Lactose LE is MEGGLE’s protective sieved product,...

We invite you to read the below product spotlights of IOI Oleochemicals. IMWITOR® 742 Chemical Description / Monograph Name: Glyceryl...

Abstract The disadvantages of some conventional drugs, including their low bioavailability, poor targeting efficiency, and important side effects, have led...

Transdermal administration remains an active research and development area as an alternative route for long-acting drug delivery. It avoids major...

Abstract Parenteral administration is one of the most commonly used drug delivery routes for nanoparticle-based dosage forms, such as lipid-based...

DFE Pharma is a global leader in pharma and nutraceutical excipient solutions. They develop, produce and supply high quality functional...

BioHale® is  DFE Pharma´s, high-purity, low-endotoxin product portfolio for the stabilization of biologics. Because stability matters. BioHale® Key promises: Uncompromised...

A broad, versatile range of standard, custom and specialized parenteral excipients The RESOMER® and LACTEL® portfolios provide an industry-leading selection...

On March 11th, 2024, BASF Pharma Solutions officially announced the launch of Kolliphor® P188 Cell Culture – This new shear protectant is a...